"Let our investigators test your new pharmaceutical products in our research center. For more details, contact Providence Clinical Research in North Hollywood, CA."

During the past decade, Providence Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 44 clinical trials were completed, i.e. on average, 209.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 23 clinical trials were completed. i.e. 383.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Clinical Research" #1 sponsor was "Pfizer" with 13 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials sponsored, "Endo Pharmaceuticals" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Clinical Research" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Providence Clinical Research" are "Chronic Pain" (5 trials), "Low Back Pain" (5 trials), "Osteoarthritis" (5 trials), "Osteoarthritis, Knee" (5 trials) and "Atopic Dermatitis" (4 trials). Many other conditions were trialed in "Providence Clinical Research" in a lesser frequency.

Most popular intervention types in "Providence Clinical Research" are "Drug" (60 trials), "Biological" (14 trials), "Other" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Naproxen" (4 trials), "placebo" (4 trials), "Famciclovir" (2 trials) and "Hydrocodone ER" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Clinical Research" are 72 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Clinical Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Providence Clinical Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Clinical Research, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".